- $6.05bn
- $5.19bn
- $147.17m
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
Grail rises as $110 mln Samsung-backed funding boosts cancer test expansion
U.S. STOCKS ON THE MOVE-Grail, Kohl, Virgin Galactic
Grail shares fall after large cancer blood test data yields mixed results
Brief: Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses
Brief: Superpower Announces Strategic Partnership With GRAIL For Multi-Cancer Early Detection Test
Grail CEO Bob Ragusa to retire, Josh Ofman named successor
U.S. STOCKS ON THE MOVE-Homebuilders, solar stocks, Alphabet
Grail shares plummet after UK study raises doubts over cancer test's prospects (updated)
U.S. STOCKS ON THE MOVE-Comfort Systems, Funko, Paymentus
U.S. STOCKS ON THE MOVE-Deckers Outdoor, CDT Equity, Comfort Systems
Grail shares plunge after major cancer screening trial misses main goal
U.S. STOCKS ON THE MOVE-Akamai, Grail, Candel Therapeutics
Grail tumbles after cancer‑detection test fails in large study
Grail slumps after Q4 results, cancer test misses main study goal
Brief: Grail Says Primary Endpoint Of Statistically Significant Combined Stage III-IV Reduction Was Not Met
U.S. RESEARCH ROUNDUP-Applied Materials Inc, Blackstone Mortgage, Brookdale Senior Living
Brief: Grail Inc - May Offer Common Stock Up To $300 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Bitfarms, Progyny, ManpowerGroup